Should Drug Manufacturers - Specialty & Generic Stock Viatris Inc (VTRS) Be in Your Portfolio Monday?

Viatris Inc (VTRS) is near the top in its industry group according to InvestorsObserver. VTRS gets an overall rating of 48. That means it scores higher than 48 percent of stocks. Viatris Inc gets a 78 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 137 out of 148 industries.

VTRS has an Overall Score of 48. Find out what this means to you and get the rest of the rankings on VTRS!

See Full VTRS Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Viatris Inc Stock Today?

Viatris Inc (VTRS) stock is down -0.69% while the S&P 500 is up 0.39% as of 12:24 PM on Monday, Mar 20. VTRS has fallen -$0.07 from the previous closing price of $9.43 on volume of 5,041,492 shares. Over the past year the S&P 500 is lower by -11.86% while VTRS has fallen -13.00%. VTRS earned $1.71 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 5.49. Click Here to get the full Stock Report for Viatris Inc stock.